Douglas P. Zipes MD
Distinguished Professor, Professor Emeritus of Medicine, Pharmacology and Toxicology, Emeritus Director of the Division of Cardiology and Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IndianaDr. Douglas P. Zipes is Distinguished Professor, Professor Emeritus of Medicine, Pharmacology and Toxicology, and Emeritus Director of the Division of Cardiology and Krannert Institute of Cardiology at Indiana University School of Medicine. He received his medical degree from Harvard Medical School and trained at Duke University Medical Center in medicine and cardiology. He joined Indiana University in 1970, became Distinguished Professor in 1994, and then Director of Cardiology (1995–2004).
Having published almost 1000 medical articles and 16 textbooks with multiple editions, Dr. Zipes is the recipient of numerous awards from the American Heart Association, the Heart Rhythm Society, the American College of Cardiology, and the European Society of Cardiology, among other professional societies and institutions.
He is past president of the American College of Cardiology and the Heart Rhythm Society, and past chair of the American Board of Internal Medicine. He is a fellow of the Heart Rhythm Society, American Heart Association, European Society of Cardiology. He is Master of the American College of Physicians and American College of Cardiology, and he is a member of the American Society for Clinical Investigation and the Association of American Physicians. In addition, Dr. Zipes retains honorary membership in the Cardiac Society of Australia and New Zealand, Argentine Society of Cardiology, Hungarian Society of Cardiology, and Israel Heart Society.
Recent Contributions to PracticeUpdate:
- QT Intervals in Patients With COVID-19 Treated With Hydroxychloroquine With or Without Azithromycin
- Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine ± Concomitant Azithromycin in COVID-19
- The Utility of Rapid Atrial Pacing Immediately Post TAVR to Predict the Need for Pacemaker Implantation
- Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment
- What Have You Got To Lose? Only Your Life.
- The NCDR Left Atrial Appendage Occlusion Registry
- ACC: Clinical Implications of the NCDR Left Atrial Appendage Occlusion (LAAO) Registry
- Noninvasive Localization of Cardiac Arrhythmias Using Electromechanical Wave Imaging
- The TREAT AF Randomized Clinical Trial
- Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension